JACOBS LEVY EQUITY MANAGEMENT, INC
Position in NBIX — Neurocrine Biosciences Inc
CIK 884414
FLORHAM PARK, NJ
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$68,540,238
+$63,586,684 QoQ
Shares Held
520,269
+1389.6% QoQ
Ownership
0.517%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 76.58845712506415.ToString("F0")%
Shared 0.ToString("F0")%
None 23.41154287493585.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $198,176,624 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
520,269 | $68,540,238 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
577,645 | $43,814,373 | |
| 3 | ZTS |
Zoetis Inc.
|
304,877 | $36,039,510 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
3,632,477 | $12,749,994 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,004,373 | $9,561,630 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
420,123 | $7,347,951 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
114,018 | $6,306,335 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
188,186 | $4,253,003 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,540,238 | 520,269 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,953,554 | 34,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,986,297 | 35,520 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $6,787,260 | 54,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,833,999 | 88,915 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,171,298 | 67,189 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $60,394,636 | 524,168 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $99,272,047 | 721,087 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $98,309,100 | 712,798 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $99,197,492 | 752,865 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $77,892,075 | 692,374 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $41,063,312 | 435,454 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $43,659,829 | 431,336 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,656,940 | 64,107 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,440,951 | 13,567 | Shares | Sole | 2022-11-15 | |
| 2020-12-31 | $604,621 | 6,308 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,027,212 | 31,481 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,359,148 | 27,534 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $13,020,928 | 150,444 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||